Loading
Latest filing published 25 Jul 2025 for Elite Pharmaceuticals INC, €8,237.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 25 July 2025, Kirko Kirkov disclosed an open-market purchase of €8,237 in Elite Pharmaceuticals Inc. No broader history exists yet. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration